We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Selcia and Heptares Therapeutics Announce New Fragment Screening Collaboration

News   Apr 19, 2012

 
Selcia and Heptares Therapeutics Announce New Fragment Screening Collaboration
 
 
 

RELATED ARTICLES

Grant Fuels Drug Discovery Efforts for ALS

News

Scientists have received a $3.1 million grant to collaborate and investigate drug therapies for amyotrophic lateral sclerosis (ALS).

READ MORE

Mastering the Tricky Task of Measuring Tiny Nanoparticles

News

Researchers have determined that measuring the range of sizes in nanoparticles — instead of just the average particle size — is optimal for most applications.

READ MORE

Drug Targets Early Instigator of Alzheimer's Disease

News

Therapeutic efforts to target "plaques and tangles", considered classic hallmarks of Alzheimer's disease, have previously met with dispiriting failure. Now researchers are exploring a drug called "DYR219" – its strength lies in the fact that it can target both plaques and tangles.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE